Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth

• click to rate

  Posted by Two Blokes May 2 - Filed in Stock - 4 views
  
  AMGN beats first-quarter estimates for earnings and sales. Sales of most of its products, Prolia, Xgeva, Repatha, Blincyto and Evenity beat estimates.